NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Celtarys Research

Celtarys Research

Private
Santiago de CompostelaHealthcare & Life Scienceshttps://www.celtarys.com/

Last Round

Grant

Apr 17, 2023

Total Funding Raised

$1.29M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Celtarys Research is a biotechnology company that develops and commercializes chemical tools, such as fluorescent ligands, to improve the efficiency of the drug discovery process.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

fluorescent ligandsassay kitsdrug discovery toolsnon-radioactive assayshigh-throughput screeningHTSGPCRsbinding assaystargeted protein degradationchemical probescustom ligand developmentCRO serviceslead optimizationfluorescent tracersE3 ligase

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Celtarys Research Comps

Public and private peers based on sector, stage, and business model.

Celtarys Research comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Celtarys Research Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 17, 2023
GrantJan 1, 2023
SeedSep 24, 2021

Key People

Founding team and executive leadership

Maria Majellaro

Co-founder And Chief Scientific Officer

Founding Team

Wilson Gomes

Chief Executive Officer

Executive Team

Celtarys Research Investors

Notable investors and investment history

Celtarys Research investors
InvestorRounds
Center for Technological Development and InnovationGrant
XesgaliciaSeed
Vigo ActivoSeed
Women TechEUGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Monthly visitors grew 3988% MoM, reaching 4.1K.

  • Nov 7, 2025

    Monthly visitors increased 33% MoM.

Celtarys Research Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Celtarys Research Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Celtarys Research's valuation, stock price, and market status.

Firmographic Details

HeadquartersSantiago de Compostela
Employee Range14
Year Founded2021
Last FundingApr 17, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.